biomee ApS: Financial statements 2022
CVR: 29829586
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
biomee ApS (CVR 29829586) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,551,834 and a net result of DKK 3,602,319 compared with DKK 7,786,490 the year before. That is a decrease of 58.8% compared with the year before. Equity in the 2022 report amounted to DKK 3,809,928. The solvency ratio was 80%.
- Gross Profit
- DKK 3,551,834
- Profit/Loss
- DKK 3,602,319
- Equity
- DKK 3,809,928
- Total Assets
- DKK 4,763,225
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3.6 mio. | 3.6 mio. | 3.8 mio. | - |
| 2021 | - | 8.6 mio. | 7.8 mio. | 208 t. | - |
| 2020 | - | -461 t. | -2.8 mio. | -57.6 mio. | - |
| 2019 | - | -273 t. | -2.4 mio. | -54.8 mio. | - |
| 2018 | - | -386 t. | -2.4 mio. | -52.4 mio. | 0 |
Official annual report
Keep an eye on biomee ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Biomee ApS has published its annual report for 2021. Gross profit came to DKK 8,630,918, and the net result was DKK 7,786,490.
About biomee ApS
biomee ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2006. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named DRUG DELIVERY SOLUTIONS ApS and TOXICELL ApS. The management consists of Trine Ahlgreen. The company is owned by MC2 Therapeutics A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 4,813,840 and a net result of DKK 6,548,744 compared with DKK 5,547,134 the year before. Equity in the 2025 report amounted to DKK 23,772,837.